Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02090127 |
| Title | Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient |
| Recruitment | No longer available |
| Gender | female |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | AVEO Pharmaceuticals, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| START | San Antonio | Texas | 78229 | United States | Details |